Persist® Biochar and Persist® PAF Bioliquid Earn California OIM Certification
CAMARILLO, Calif.--(BUSINESS WIRE)-- VGrid Energy Systems, a California-based renewable energy company and maker of Persist ® Plant and Soil Enhancers, announced today that its two flagship products—Persist® Biochar and Persist® PAF Bioliquid—have both been certified as Organic Input Materials (OIM) by the California Department of Food and Agriculture (CDFA). This certification confirms that both products meet the rigorous standards required for use in certified organic farming and food production.
Persist® PAF is a liquid plant and soil enhancer containing organic acids, phenols, and beneficial biomolecules that enhance flowering, yield, and overall soil productivity.
Share
The CDFA OIM certification is one of the country's most respected and stringent organic certifications. It verifies that agricultural inputs comply with California's environmental and organic production regulations and meet the National Organic Program (NOP) standards. In addition to this certification, both products remain OMRI Listed® for use in USDA certified organic production and are verified by the USDA's BioPreferred® Program as 100% biobased.
'Earning OIM certification is a major milestone for Persist and the growers we serve,' said Jeff Norton, Vice President of Business Development. 'These certifications reinforce our commitment to delivering effective and sustainable solutions that improve soil health, boost plant productivity, and support organic and regenerative agriculture.'
Persist® Biochar is a carbon-rich soil amendment made from plant biomass, specifically pistachio shells. It improves soil structure, water retention, microbial activity, and long-term carbon sequestration.
Persist® PAF is a liquid plant and soil enhancer containing organic acids, phenols, and beneficial biomolecules that enhance nutrient availability, plant stress response, and soil microbial activity.
Both products are manufactured by VGrid Energy Systems using a proprietary biomass-to-energy technology that upcycles agricultural waste into high-value agricultural inputs and renewable electricity.
Organic growers, distributors, and agricultural professionals can now incorporate Persist products with confidence, knowing they meet the highest standards for organic production.
For more information or to request samples, visit www.persistproducts.com or email info@vgridenergy.com.
VGrid Energy Systems is a carbon-negative, renewable energy producer on a mission to reverse climate change. The company's innovative Bioserver® processes agricultural waste into 100% renewable electricity while creating valuable biochar and bioliquids that naturally improve crop yields and soil productivity. For more information, please visit www.vgridenergy.com and www.persistproducts.com.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Forbes
22 minutes ago
- Forbes
There's No Apple iOS 19: iPhone 17 To Have iOS 26 In Radical Change, Report Claims
Updated May 30 with more details of the new OS coming to the iPhone, Mac and beyond, and what it means for naming of hardware. Apple is about to radically overhaul its iPhone and other software this year, and it looks like that will even mean make massive changes to the way it names its operating systems, according to a new report. So, the software predicted to be called iOS 19 will actually be iOS 26. Here's what it means — and how it will affect other products in the Apple ecosystem, too, as Bloomberg has just commented. More on that below. On June 9, Apple is set to hold this year's World Wide Developers Conference in Cupertino, California. As part of what's predicted to be the most sweeping software overhaul in more than a decade, Apple will change its naming system out of all recognition. This could have repercussions for the hardware Apple releases, too. Instead of iOS 19, iPadOS 19, macOS 16, tvOS 19 and visionOS 2, Apple will standardize the numbers so they all refer to a year, specifically next year, rather like the way automobiles are named for the upcoming year. This is all according to a new report from Bloomberg's Mark Gurman, who claims the change is 'to bring consistency to its branding.' In a way, it's been brewing for a while, for example with tvOS and iPadOS already having the same number as iOS, even when the number of updates has been widely different. 'The next Apple operating systems will be identified by year, rather than with a version number, according to people with knowledge of the matter. That means the current iOS 18 will give way to 'iOS 26,' said the people, who asked not to be identified because the plan is still private. Other updates will be known as iPadOS 26, macOS 26, watchOS 26, tvOS 26 and visionOS 26,' Gurman claims. There's a logic to this when some operating systems use one number, while others have completely different ones. If cohesion is the goal, this makes sense. Samsung changed the names of its Galaxy S phones to match the year of release back in 2020 with the Galaxy S20. Since the Galaxy S series is announced early in the year, often as soon as January, it understandably matches the number to the current year. And Apple has done something similar in the past when it had software products like iLife and iWork. The August 2007 releases were called iLife 08 and iWork 08, with iLife 11 going on sale in October 2020, as Gurman points out. But wait, I hear you ask, what about the naming of the macOS version? Since OSX, as it was then called, Apple enjoyed naming Mac software after big cats, and then parts of California. In fact, WWDC always had a comical highlight when exec Craig Federighi lightly teased his colleagues in marketing for how they came up with the new name. Well, the new system doesn't preclude a suffix being added, so it could be macOS 26 Miramar, or whatever. But it doesn't seem likely. WWDC won't be the same. What I don't think will happen is that the iPhone names will follow suit. To introduce iPhone 26 instead of iPhone 17 seems far-fetched, especially because the iPhone 16, which will certainly remain in the range, would sound suddenly terribly old-fashioned. But we'll see. The first reveal is less than two weeks away in the WWDC keynote on Monday, June 9. Mark Gurman has also weighed in on the naming of the iPhone. 'It's a good question for SEO, but I would be surprised if Apple moved to the 'iPhone 26' this year,' he commented on X. I agree, though I note in passing that Apple surprised everyone back in 2011 when instead of releasing the iPhone 5, we saw the iPhone 4s. Every editor relying on SEO that I knew at the time went into a hot panic. One other thing: there's a benefit to this new software naming system if you're me, and you keep forgetting that watchOS and Apple Watch releases are just one number out of sync. Apple Watch Series 10 launched alongside watchOS 11. I have confused the numbering on either the hardware or the software more times than I care to remember.
Yahoo
23 minutes ago
- Yahoo
PepGen Inc. (PEPG) Halts DMD Program After Trial Miss; Shifts Focus to DM1
Boston-based biotech PepGen Inc. (NASDAQ:PEPG) announced today it will discontinue all Duchenne muscular dystrophy (DMD) research after its lead candidate, PGN-EDO51, failed to achieve target dystrophin levels in the CONNECT1-EDO51 trial. Despite being well tolerated at 10 mg/kg, PGN-EDO51 only increased dystrophin to 0.59% of normal levels, falling short of expectations. All treatment-related adverse events were mild, and no serious events were reported. A healthcare professional in a meeting with a patient discussing care options using digital technology. 'We are disappointed by the results and will wind down our DMD program,' said CEO James McArthur, PhD, thanking patients and staff for their support. PepGen Inc. (NASDAQ:PEPG) will now focus on its promising myotonic dystrophy type 1 (DM1) program, PGN-EDODM1, which has shown robust target engagement and a favorable safety profile. PepGen Inc. (NASDAQ:PEPG) expects data from its Phase 1 FREEDOM-DM1 trial's 15 mg/kg cohort in the second half of 2025, and from the Phase 2 FREEDOM2-DM1 5 mg/kg cohort in early 2026. PGN-EDODM1, which has Orphan Drug and Fast Track status, targets the genetic root of DM1, a rare, life-shortening disorder with no approved treatments. While we acknowledge the potential of PEPG to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than PEPG and that has 100x upside potential, check out our report about this READ NEXT: and Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Bloomberg
33 minutes ago
- Bloomberg
Wall Street or Vegas: Kalshi Ramps Up Battle Over Legal Gambling
By During its short existence, Kalshi has taken a battering ram to the regulatory establishment in its bid to give Americans the inalienable right to bet on just about everything. The US election, Taylor Swift's next hit, volcanic eruptions, and even the Rotten Tomatoes score for "How to Train Your Dragon." Now, the seven-year old financial exchange is taking it to a whole new level by using its federal financial license to open up sports gambling nationwide, even in states where it is not legal.
